Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FB7012
- Development stage
- Preclinical
- Lead developer
- Frontier Biotechnologies
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
FB7012 is an investigational small RNA (siRNA) therapeutic candidate being developed by Frontier Biotechnologies for the treatment of hyperuricemia and gout. It is part of the company's oligonucleotide-based drug pipeline, which utilizes RNA interference (RNAi) technology to target specific genetic pathways involved in disease progression. While the specific molecular target of FB7012 has not been publicly disclosed, the drug is designed to address the underlying metabolic dysfunction associated with elevated uric acid levels. It is currently in the early stages of development as Frontier Biotechnologies expands its portfolio beyond its established HIV and anti-infective products into metabolic and inflammatory diseases.
Beyond the preview
Go deeper on FB7012.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FB7012.